Cargando…
Controlling the drug-resistant tuberculosis epidemic in India: challenges and implications
India has a higher tuberculosis (TB) burden than any other country, accounting for an estimated one-fourth of the global burden. Drug-resistant tuberculosis (DR-TB) presents a major public health problem in India. Patients with DR-TB often require profound changes in their drug regimens, which are i...
Autores principales: | Husain, Aliabbas A., Kupz, Andreas, Kashyap, Rajpal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Epidemiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189845/ https://www.ncbi.nlm.nih.gov/pubmed/33831293 http://dx.doi.org/10.4178/epih.e2021022 |
Ejemplares similares
-
Impact of COVID-19 pandemic on tuberculosis care in India
por: Husain, Aliabbas A., et al.
Publicado: (2021) -
Diagnostic Challenges and Prospects Associated With Zoonotic Tuberculosis of Central Nervous System
por: Bapat, Prachi R., et al.
Publicado: (2020) -
Drug-resistant tuberculosis: is India ready for the challenge?
por: Chatterjee, Soumya, et al.
Publicado: (2018) -
Disease Control Implications of India's Changing Multi-Drug Resistant Tuberculosis Epidemic
por: Suen, Sze-chuan, et al.
Publicado: (2014) -
Assessment of immunological markers and booster effects of Ag85B peptides, Ag85B, and BCG in blood of BCG vaccinated children: a preliminary report
por: Husain, Aliabbas A., et al.
Publicado: (2016)